This is a prospective, single-blinded, randomized controlled trial to evaluate whether PTeyeâ„¢ can reduce post-operative hypoparathyroidism (PH). The study will enroll consecutive patients undergoing total thyroidectomy in a teritary endocrine surgery unit in Hong Kong, randomizing them into receiving conventional surgery versus PTeyeâ„¢-assisted surgery. Subjects will be assigned to the two groups before surgery. Subjects will be under medical care as in usual practice.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Rate of significant post-operative hypoparathyroidism (SPH) after total thyroidectomy (in %)
Timeframe: 6 months